Abstract:Cysteine-altering missense variants (NOTCH3cys) in one of the 34 epidermal growth-factor-like repeat (EGFr) domains of the NOTCH3 protein are the cause of NOTCH3-associated small vessel disease (NOTCH3-SVD). NOTCH3-SVD is highly variable, ranging from CADASIL at the severe end of the spectrum to non-penetrance. The strongest known NOTCH3-SVD modifier is NOTCH3cys variant position: NOTCH3cys variants located in EGFr domains 1-6 are associated with a more severe phenotype than NOTCH3cys variants located in EGFr domains 7-34. The objective of this study was to further improve NOTCH3-SVD genotype-based risk prediction by using relative differences in NOTCH3cys variant frequencies between large CADASIL and population cohorts as a starting point. Scientific CADASIL literature, cohorts and population databases were queried for NOTCH3cys variants. For each EGFr domain, the relative difference in NOTCH3cys variant frequency (NVFOR) was calculated using genotypes of 2574 CADASIL patients and 1647 individuals from population databases. Based on NVFOR cut-off values, EGFr domains were classified as either low (LR-EGFr), medium (MR-EGFr) or high risk (HR-EGFr). The clinical relevance of this new 3-tiered EGFr risk classification was cross-sectionally validated by comparing SVD imaging markers and clinical outcomes between EGFr risk categories using a genotype-phenotype dataset of 434 CADASIL patients and 1003 NOTCH3cys positive community-dwelling individuals. CADASIL patients and community-dwelling individuals harbored 379 unique NOTCH3cys variants. Nine EGFr domains were classified as a HR-EGFr, which included EGFr domains 1-6, but additionally also EGFr domains 8, 11 and 26. Ten EGFr domains were classified as MR-EGFr and 11 as LR-EGFr. In the population genotype-phenotype dataset, HR-EGFr individuals had the highest risk of stroke (OR = 10.81, 95%CI:5.46–21.37), followed by MR-EGFr individuals (OR = 1.81, 95%CI:0.84–3.88) and LR-EGFr individuals (OR = 1 [reference]). MR-EGFr individuals had a significantly higher normalized white matter hyperintensity volume (nWMHv)(P = 0.005) and Peak Width of Skeletonized Mean Diffusivity (PSMD)(P = 0.035) than LR-EGFr individuals. In the CADASIL genotype-phenotype dataset, HR-EGFr domains 8, 11 and 26 patients had a significantly higher risk of stroke (P = 0.002), disability (P = 0.041), nWMHv (P = 1.8 × 10−8), PSMD (P = 2.6 × 10−8) and lacune volume (P = 0.006) than MR-EGFr patients. SVD imaging marker load and clinical outcomes were similar between HR-EGFr 1-6 patients and HR-EGFr 8, 11 and 26 patients. NVFOR was significantly associated with vascular NOTCH3 aggregation load (P = 0.006), but not with NOTCH3 signalling activity (P = 0.88). In conclusion, we identified three clinically distinct NOTCH3-SVD EGFr risk categories based on NFVOR cut-off values, and identified three additional HR-EGFr domains located outside of EGFr domains 1-6. This EGFr risk classification will provide an important key to individualized NOTCH3-SVD disease prediction.

Phenotypic variability in 446 CADASIL patients: Impact of NOTCH3 gene mutation location in addition to the effects of age, sex and vascular risk factors

Association of NOTCH3 Variant Position With Stroke Onset and Other Clinical Features Among Patients With CADASIL

Phenotypes Associated with NOTCH3 Cysteine-Sparing Mutations in Patients with Clinical Suspicion of CADASIL: A Systematic Review

Genetic spectrum of NOTCH3 and clinical phenotype of CADASIL patients in different populations

Most common NOTCH3 mutations causing CADASIL or CADASIL-like cerebral small vessel disease: A systematic review

Protein aggregates containing wild-type and mutant NOTCH3 are major drivers of arterial pathology in CADASIL

NOTCH3 Variants in Patients with Suspected CADASIL

A Heterozygous Mutation in NOTCH3 in a Chinese Family with CADASIL

Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy: Phenotypic and Mutational Spectrum in Patients from Mainland China.

A Novel Cysteine-Sparing G73A Mutation of NOTCH3 in a Chinese CADASIL Family.

Report of two Chinese families and a review of Mainland Chinese CADASIL patients.

Three-tiered EGFr domain risk stratification for individualized NOTCH3-small vessel disease prediction

Disease Severity Staging System for NOTCH3-Associated Small Vessel Disease, Including CADASIL.

NOTCH3 variants are more common than expected in the general population and associated with stroke and vascular dementia: an analysis of 200 000 participants

Clinical and neuroradiological spectrum of biallelic variants in NOTCH3

Heterogeneity of NOTCH3 activation mechanisms uncovers therapeutic potential for targeted therapies for CADASIL.

Peripheral arteriopathy caused by Notch3 gain-of-function mutation involves ER and oxidative stress and blunting of NO/sGC/cGMP pathway

Broad phenotype of cysteine-altering NOTCH3 variants in UK Biobank: CADASIL to nonpenetrance

A novel cysteine-sparing NOTCH3 mutation in a Chinese family with CADASIL

Notch3 Mutations And Clinical Features In 33 Mainland Chinese Families With Cadasil

Identification of a Known Mutation in Notch 3 in Familiar CADASIL in China